ArticleOncology letters2020

Interferon-β sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02.

Birthe Lohmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.